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Geldanamycin analogsRotaviruses are the major cause of severe dehydrating gastroenteritis in children worldwide. In this study, we
report a positive role of cellular chaperone Hsp90 during rotavirus infection. A highly speciﬁc Hsp90
inhibitor, 17-allylamono-demethoxygeldanamycin (17-AAG) was used to delineate the functional role of
Hsp90. In MA104 cells treated with 17-AAG after viral adsorption, replication of simian (SA11) or human
(KU) strains was attenuated as assessed by quantitating both plaque forming units and expression of viral
genes. Phosphorylation of Akt and NFκB observed 2–4 hpi with SA11, was strongly inhibited in the presence
of 17-AAG. Direct Hsp90–Akt interaction in virus infected cells was also reduced in the presence of 17-AAG.
Anti-rotaviral effects of 17-AAG were due to inhibition of activation of Akt that was conﬁrmed since, PI3K/Akt
inhibitors attenuated rotavirus growth signiﬁcantly. Thus, Hsp90 regulates rotavirus by modulating cellular
signaling proteins. The results highlight the importance of cellular proteins during rotavirus infection and the
possibility of targeting cellular chaperones for developing new anti-rotaviral strategies.© 2009 Elsevier Inc. All rights reserved.Introduction
Cells induce a stress response to virus infection, which results in
the expression of stress response proteins like heat shock proteins
(Hsps) (Sullivan and Pipas, 2001). It has been reported that both DNA
and RNA viruses induce Hsps, independent of the cytoplasmic or
nuclear location of their replication however the type of Hsp induced,
depends on the virus or the cell type (Sedger and Ruby, 1994; Sullivan
and Pipas, 2001). Hsp family members including Hsp40, 70 and 90
(40-, 70-, 90-kDa heat shock proteins) are also important molecular
chaperones which regulate various cellular processes such as protein
folding, transport, cell viability etc (Welch, 1991). While some viruses
in the Polyomaviridiae and Closteroviridiae families encode their own
viral speciﬁc chaperone proteins, most of the viruses have been shown
to directly or indirectly depend on one or more cellular chaperones
including, Hsp40 (Glotzer et al., 2000; Kumar andMitra, 2005), Hsp70
(Mayer, 2005), Hsp90 (Hu and Seeger, 1996; Gilmore et al., 1998;
Hung et al., 2002; Burch and Weller, 2005; Kampmueller and Miller,
2005; Okamoto et al., 2006; Connor et al., 2007; Naito et al., 2007;@icmr.org.in
ll rights reserved.Chase et al., 2008; Ujino et al., 2009) and cyclophilins (Franke et al.,
1994) to complete their replication. There are overwhelming
evidences suggesting the dependence of both DNA and RNA viruses
on cellular chaperones however functional mechanism varies among
different viruses and host systems (Hu and Seeger, 1996; Hung et al.,
2002; Mayer, 2005; Connor et al., 2007).
Hsp90 is a constitutive, atypical member of the molecular
chaperone family present in eukaryotes and bacteria. It is an
extremely abundant protein, comprising ∼1–2% of total cellular
protein (Powers and Workman, 2006). Hsp90 displays ATP-depen-
dent folding capacity and has been shown to bind during later stages
of protein folding for facilitating the activation-competent state, with
the help of its various co-chaperones and ATP (Nollen and Morimoto,
2002; Pearl and Prodromou, 2006; Powers and Workman, 2006).
Unlike the other promiscuous cousin chaperone Hsp70, Hsp90
appears to have a speciﬁc set of client proteins (Nollen and Morimoto,
2002; Pearl and Prodromou, 2006). The common denominator of the
Hsp90 client proteins, is their role as regulators of signal transduction
pathways involved in cell cycle or survival, thus maintaining cellular
homeostasis (Zhang and Burrows, 2004; Citri et al., 2006). The Hsp90
may contribute to viral replication either by modulating the cellular
signaling mechanisms (Sun et al., 2008) or by direct interactions with
viral proteins such as hepatitis B (HBV) reverse transcriptase, hepatitis
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and vesicular stomatitis viruses (Hu and Seeger, 1996; Connor et al.,
2007; Naito et al., 2007; Chase et al., 2008; Ujino et al., 2009).
Rotavirus is a double stranded RNA virus associated with severe
dehydrating gastroenteritis in children worldwide. Children from
underdeveloped countries, account for N80% of the rotavirus associated
deaths (Rossen et al., 2004; Estes and Kapikian, 2007). The infectious
virion is a non-enveloped,11 dsRNA segmented genome surrounded by
three concentric layers of protein. Rotavirus generally infects and
replicates in mature enterocytes of the small intestine, leading to
induction of inﬂammatory cytokines, reduced expression of enterocyte
genes and vacuolization (Estes and Kapikian, 2007). Involvement of
Hsc70 (70-kDa heat shock cognate protein) in themultistep entry of RV
into intestinal epithelial cells and induction of heat shock protein
transcripts following viral infection has been reported previously
(Cuadras et al., 2002; Guerrero et al., 2002). However unlike the
positive role of Hsps in facilitating replication in case of Inﬂuenza orHBV
viruses, Hsp70was found to negatively control RV infection by directing
viral proteins towards ubiquitin dependent degradation. Silencing of
Hsp70 resulted in increased translation of rotavirus proteins (Broquest
et al., 2007). In spite of the induction of Hsps during rotavirus infection,
there is no information till date about the role of cellular Hsp90 in
regulating rotavirus growth and replication.
To elucidate the role of molecular chaperone Hsp90 in rotavirus
replication, we utilized 17-allylamono-demethoxygeldanamycin (17-
AAG; NSC 330507), a highly speciﬁc but less toxic analogue of the
benzoquinone ansamycin antibiotic geldanamycin (Sausville et al.,
2003). Geldanamycin and its analogs bind to the ATP-binding pocket
on Hsp90 and interferes with its chaperone functions (Stebbins et al.,
1997). A signiﬁcant reduction (∼1.5–1.8 log) in viral titers was observed
in the presence of 17-AAG in a dose and time dependentmanner. To our
knowledge this is the ﬁrst report showing involvement of Hsp90 as a
modulator of rotavirus infection. In an attempt to address the possible
molecular mechanism of 17-AAG mediated regulation of virus growth
we have identiﬁed a positive role of Hsp90 client proteins, Akt and NFκB
during rotavirus infection. The results emphasize an important role of
cellular proteins during infection of rotaviruses.
Results
Inhibition of Hsp90 suppresses the rotavirus replication
The cytotoxicity of 17-AAG was tested in mock-infected MA104
cells treated with increasing concentrations of the inhibitor for 12–
48 h in serum free conditions by measuring cell viability using MTS
reduction assay measuring metabolic activity of cells. There were
96.5–94.6%; 92.2–88.5% and 87.7–83.3% viable cells at 24–48 h post
treatment in the presence of 2.5 μM–5 μM–10 μM of 17-AAG
respectively. More than 80% viable cells after 48 h of treatment with
5–10 μM 17-AAG was also conﬁrmed by neutral red dye uptake assay.
After 24 and 48 h, 97% and 93.8% viable cells were observed in DMSO
(b0.4%) treated control cells in serum free conditions (Fig. 1A). Cell
extracts prepared after 48 h were also subjected to immunoblotting
using Hsp90 antibody to assess the effects of 17-AAG on Hsp90
expression. A 2–3 fold decrease in Hsp90 expression was observed
following treatment with 5–10 μM of 17-AAG for 48 h (Fig. 1A).
To assess whether Hsp inhibitor 17-AAG, could modulate rotavirus
growth, MA104 cells were infected with prototype strain SA11 (moi 1).
After adsorption, cells were incubated at 37 °C in maintenance media
containing either 17-AAG (2.5–10 μM) or DMSO control. Cells were
harvested at 20 hour post infection (hpi) and viral titers were
determined using plaque assay. SA11, a fast growing strain has high
infectivity rate (N90%) in MA104 cells and results in N80% loss of cell
viability within 24 h. Compared to no drug controls, 17-AAG reduced
viral titers in a dose dependent manner. At 5 μM and 10 μM dose, there
was reduction in viral titer by 1.6–1.8 log and 2.1–2.2 log (pb0.01)respectively (Fig. 1B). The data suggested that for efﬁcient rotavirus
replication, functional Hsp90 chaperone complex is required. Subse-
quentexperimentswere carriedoutwith the effective but less toxic dose
(5 μM) of 17-AAG. To understand whether 17-AAG affects early or late
stages of viral life cycle, a time course study of viral growth was done.
The MA104 cells were infected with SA11 (simian) and KU (human)
strains (moi 1) and recovered in the absence or presence of 17-AAG.17-
AAG had a signiﬁcant effect on slowing virus growth and showed
noticeable delay in virus growth as early as 8 h in fast growing strain
SA11 and 16 h in slow growing human strain KU compared to only virus
infected DMSO controls. At the end point, therewas 1.6–1.7 log and 1.2–
1.4 log reduction in viral titers of SA11 and KU in the presence of 17-AAG
(Fig. 1C). To assess whether Hsp90 function is required during early or
late stages of infection,MA104 cellswere infectedwith SA11and17-AAG
was added to the media at 0 hpi, 2 hpi and 4 hpi. After 20 h of infection,
cellswere harvested and viral titerswere estimated. As shown in Fig.1D,
17-AAG signiﬁcantly inhibited virus growth even when added 2 hpi
(0.8–1.0 log), however the inhibitory effect was reducedwhen drugwas
added after 4 h of infection (b0.3 log) indicating the importance of
Hsp90 chaperone activity during early stages of infection.
To elucidate the effect of Hsp90 inhibition on expression of viral
genes, MA104 cells were infected with strain SA11 (moi 3) in the
presence of either 17-AAG or only DMSO. Cells were harvested at 8 hpi
and viral VP6 (viral protein 6; inner capsid) and NSP4 transcripts were
quantitated in triplicates by real time PCR using gene speciﬁc primers
and GAPDH as endogenous control. There was 2.2–2.4 fold (pb0.05)
reduction in VP6 and NSP4 transcripts (Fig. 1E). The decrease in
expression of viral genes was further validated by assessing decrease in
levels of viral proteins in the presence of 17-AAG by immunoblotting.
Cellular extracts prepared at 12 hpi in the presence of 17-AAG showed
2.72, 2.4 and 3.0 fold decrease in expression of VP6, NSP4 and NSP1
proteins respectively compared to only virus treated controls (Fig. 2A).
The speciﬁcity of 17-AAG for HSP90 facilitates the study of HSP90-
dependent cellular pathways. However, to independently conﬁrm the
role of HSP90 in rotavirus replication in MA104 cells using a genetic
approach that did not rely on pharmacological inhibitors; we used
RNAi to selectively downregulate the expression of HSP90. MA104
cells were transiently transfected with Hsp90 speciﬁc or matched
negative control siRNAs for two consecutive days. After 24 h of second
transfection, a 2 fold reduction in hsp90 was observed compared to
controls (Fig. 2B). siRNA transfected MA104 cells were infected with
SA11 and rotavirus growth was measured by quantitating VP6
transcript by real time PCR and protein expression by immunoblot-
ting. Compared to only virus controls, more than 2.0 fold decrease in
viral transcripts and VP6 protein expression was observed in Hsp90
siRNA transfected cells (Figs. 2C, D) conﬁrming the functional role of
Hsp90 during rotavirus growth. A 9–10% decrease (pN0.05) observed
in the matched negative control siRNA transfected cells could be due
to non speciﬁc toxicity associated with transfection (Fig. 2D).
Inhibition of rotavirus replication by 17-AAG correlates to
downregulation of virus induced Akt phosphorylation
Based on previous reports regarding activation of PI3K/Akt in virus
survival (Cooray, 2004; Halasz et al., 2008; Sun et al., 2008) and
modulation of Akt by Hsp90 (Fujita et al., 2002; Zhang and Burrows,
2004), the effect of Hsp90 inhibitor on rotavirus-induced Akt infection
was analyzed. Cell lysates prepared at 4–12 hpi from cells eithermock-
infected or infected with SA11 (moi 3), were subjected to western
blotting using p-Akt (ser473) and p-GSK-3 β (glycogen synthase
kinase-3 β) antibodies. Following rotavirus infection, a 5–7 fold
increase in Akt phosphorylation was observed at 4, 8 and 12 hpi
compared to 2–3.2 fold increase in p-GSK-3 β. Therewas no signiﬁcant
change in basal Akt or GSK-3 β levels indicating that rotavirus
modulates only the activation of endogenous Akt (Fig. 3A). However,
when post infection, cells were recovered in the presence of 17-AAG,
Fig. 1. HSP90 inhibitor 17-AAG inhibits rotavirus multiplication. (A) Viability of MA104 cells cultured in serum free medium supplemented with different concentrations of 17-AAG
(0–10 μM) is shown as percent cell viability as determined by MTS reduction assay with Cell titer 96® Aqueous One Solution Cell Proliferation assay kit (Promega) following
treatment for 12, 24 and 48 h . After 48 h, cells were lysed and Hsp90 expression was analyzed by immunoblot analysis (0–10 μM). Decrease in Hsp90 expression (2–3 folds) was
observed in the presence of 17-AAG. (B) Dose dependent inhibition in viral titers (SA11) by 17-AAG as measured by plaque assay after 20 h post infection. In the presence of 5 μM–
10 μM17-AAG, 1.6–2.2 log inhibition (pb0.05; ⁎pb0.01) was observed. (C) Time kinetics of inhibition of rotavirus strains (SA11 and KU) growth in the presence (■) or absence (O) of
17-AAG (5 μM) as measured by plaque assay. At respective end points, a 1.3–1.7 log inhibitionwas observed for KU and SA11 strains respectively. (D) Role of Hsp90 in initial stages of
rotavirus infectionwas conﬁrmed by addition of 17-AAG at 0 hpi, 2 hpi and 4 hpi. Cells were lysed after 20 h of infection and viral titers were determined by plaque assay. Therewas an
increase in rotaviral titers when 17-AAG was added 2 or 4 h post infection compared to 0 hpi. (E) 17-AAG (grey bar) inhibits expression of VP6 and NSP4 gene transcripts (8 hpi) in
MA104 cells compared to only virus (black bars) infected cells, as measured by real time PCR. GAPDH was used as endogenous control. The data shown represent mean±SD of three
experiments. The decrease in viral titers and gene expression in the presence of 17-AAG was statistically signiﬁcant (pb0.05).
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of Akt (2.3–2.6 fold) and its substrate GSK-3 β (2.0–2.1 fold), was
observed compared to the only virus infected cells (Fig. 3B). Whether
the effect of 17-AAG on Akt phosphorylation was due to direct or
indirect interactions between Hsp90 and Akt was assessed by
immunoprecipitation of cell lysates prepared following rotavirus
infection (8 h) in the presence or absence of 17-AAG using Hsp90
antibody. The blots were probed with Akt and Hsp90 antibodies. As
shown in Fig. 3C, in cells infected with rotavirus, Akt co-immunopre-cipitated with Hsp90 (Fig. 3C, lane 2), which was signiﬁcantly
inhibited in virus infected cells treated with 17-AAG (Fig. 3C, lane
3). At 8 hpi, there was no difference in Hsp90 expression in the
presence or absence of 17-AAG.
To conﬁrm whether downregulation of p-Akt by 17-AAG, could be
one of the possiblemechanism of its antiviral effects, cells were infected
with strain SA11 (moi 1) in the presence of p-Akt inhibitor (triciribine
2.5 μM), PI3K inhibitor (LY294002, 10 μM), 17-AAG or DMSO controls.
Cells were harvested in a time dependent manner and viral titers were
Fig. 2. Effect of Hsp90 inhibition on rotavirus gene expression. (A) Western blot analysis of VP6, NSP4 and NSP1 expression in the presence or absence of 17-AAG (12 hpi). 17-AAG
signiﬁcantly reduced expression of VP6, NSP4 and NSP1 proteins compared to cells infected with virus in the presence of DMSO. The blots were reprobed with β-actin to conﬁrm
equal protein loading. Fold changewas quantitated bymeasuring band intensities in respect to β-actin control (n=3; pb0.05; ⁎p≤0.01). (B) Downregulation of HSP90 expression in
the presence of HSP90 siRNA (5 nM) as analyzed bywestern blotting. (C and D) Cells that were mock-transfected or transfected with HSP90 siRNA or matched negative control siRNA
were infected with SA11 (moi 3). After 8 hpi or 12 hpi, cells were lysed and viral gene VP6 transcript or protein expression was measured by RTQ PCR (C) and immunoblotting (D)
showing signiﬁcant reduction in expression of both VP6 transcripts as well as protein expression as a result of HSP90 silencing.
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reduction in viral titers was observed at 20 h compared to 1.6–1.7 log
inhibition with 17-AAG, conﬁrming the importance of virus induced
activation of PI3K/Akt during its replication (Fig. 3D). The reduction in
viral titerswasnot due to cytotoxic effects since in serum free conditions
mimicking virus infection, there were 92.6–88.8% and 90.1–85.2% cell
viability after 24–48 h of triciribine (2.5 μM) and LY294002 (10 μM)
treatment (Fig. 3E). The virus induced phosphorylation of Akt was also
inhibited, in the presence of both triciribine and LY294002 conﬁrming
correlation between inhibition of viral replication and Akt phosphoryla-
tion (data not shown). Positive role of Akt was further conﬁrmed using
Akt-1 and Akt-2 speciﬁc siRNAs. After 24 h of transfection, 60% decrease
in Akt expression was observed compared to controls. Following SA11
infection in siRNA transfected MA104 cells, expression of VP6 protein
was quantitated by immunoblotting. Compared to only virus controls,
more than3 fold decrease inVP6 protein expressionwas observed inAkt
siRNA transfected cells (Fig. 3F).
17-AAG inhibits Akt regulated mTOR signaling
Based on previous data conﬁrming positive role of Akt, we
hypothesized that 17-AAG may effect virus growth by inhibiting the
Akt substrates such as regulator of the initiation of cap-dependent
translation mTOR (mammalian target of rapamycin). Phosphorylation
of mTOR, 4EBP1 (eukaryotic initiation factor 4E binding protein 1) and
p70S6K (ribosomal p70 S6 kinase) was analyzed 12 h post infection
(SA11) in the presence or absence of 17-AAG by immunoblotting.
Rapamycin (100 nM), inhibitor of mTOR, was used as positive control.
Rotavirus infection resulted in an increase in phosphorylation ofmTOR (N10 fold), 4EBP1 (≥7 fold) and p70S6K (≥5 fold), which was
signiﬁcantly reduced in the presence of 17-AAG (Fig. 4). No change in
expression of basal mTOR, 4EBP1 or S6K protein in the presence of 17-
AAG was observed (Fig. 4).
17-AAG inhibits activation of rotavirus-induced NFκB, another Hsp90
and Akt modulated protein
Since there are reports of activation of NFκB during rotavirus
infectionandNFκB is also activatedbyPI3K/Akt andHsp90,we analyzed
whether rotavirus-induced NFκB activation is modulated by 17-AAG.
MA104 cells were infectedwith SA11 (moi 3) followed by the treatment
with either 17-AAG or DMSO, and cell extracts were prepared at 2–8 h
post infection. Immunoblotting with phospho-p65 antibody showed
increased phosphorylation of p65 subunit of NFκB following rotavirus
infection, as earlyas2–4h (2.5–3.5 fold)with subsequent decrease at8h
(Fig. 5A) conﬁrming previous observations. However there was a
signiﬁcant downregulation of p-p65 at 2 h (1.7 fold) and N4.5 fold
inhibition by 4 h in the presence of 17-AAG (Fig. 5A). Inhibition of NFκB
activation was further conﬁrmed using a luciferase reporter construct
with a 2× NFκB promoter. A strong activation of NFκB promoter as
measured by luciferase enzyme activity was observed 4 h and 8 hpi
following rotavirus infection, which was inhibited 3–5 fold (pb0.01) in
the presence of 17-AAG (Fig. 5B).
Discussion
All viruses depend on host cells for a successful infection, thus they
need to create a cellular environment which is conducive for their
Fig. 3. Effect of 17-AAG on rotavirus-induced Akt phosphorylation. (A) Western blot analysis showing phosphorylation of Akt (ser473) and its downstream substrate GSK-3 β at 4–
12 h post SA11 infection. Blots were reprobed to analyze basal expression of Akt or GSK-3 β following rotavirus infection. (B) 17-AAG (5 μM) inhibits the rotavirus (8 hpi) induced Akt
and GSK-3 β phosphorylation. No effect of 17-AAG on basal Akt or GSK-3 β expression was observed. (C) Co-immunoprecipitation of Hsp90 with Akt is signiﬁcantly reduced in the
presence of 17-AAG. Cells were either mock-infected or infected with SA11 (moi: 3) in the presence or absence of 17-AAG. Cell lysates prepared at 8 hpi were immunoprecipitated
with anti-Hsp90 antibody and separated on a 10% polyacrylamide gel. Blots were probed with Akt and Hsp90 antibody. Whole cell lysates were also loaded as internal control for Akt
and Hsp90 protein. (D) Time kinetics of inhibition of SA11 growth in the presence of inhibitors namely,17-AAG (5 μM●), triciribine (2.5 μM■), LY294002 (10 μM▴) or DMSO control
(O) for 20 h as measured by plaque assay. The data represent the mean±SD of three experiments (pb0.05). (E) Percent cell viability of MA104 cells incubated with triciribine
(2.5 μM), LY294002 (10 μM) or DMSO as determined byMTS reduction assay with Cell titer 96® Aqueous One Solution Cell Proliferation assay kit (Promega) following 12, 24 and 48 h
of treatment in serum free conditions. Individual data points represent the mean values from three independent experiments. (F) Downregulation of Akt expression by Akt siRNA
(5 nM, Ambion) after 24 h of transfection in MA104 cells as conﬁrmed bywestern blot analysis. Following Akt or negative control siRNA transfection, MA104 cells were infected with
SA11 and expression of VP6 protein was quantitated after 12 h by immunoblotting. Signiﬁcant reduction (3 fold) was observed in the expression of VP6 protein expression in the
presence of Akt siRNA (pb0.05).
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have developed the ability to exploit cellular signaling pathways
regulating, the cell survival, homeostasis or apoptosis for their beneﬁt.
Thus identiﬁcation of important cellular factors modulating viral
growth is important to not only understand virus–host interactions
but pathogenesis of the disease. Moreover the possibility of targeting
cellular proteins for developing new generation of low cost antivirals
specially in the case of short term viral infections is gaining
importance due to its implications in reducing morbidity and
mortality in developing countries (Lewis et al., 2000; Geller et al.,
2007).During the last decade, there are lots of reports regarding rotavirus
diversity and epidemiology, vaccine development, gene expression,
evasion of immune response by modulating IFN regulatory factors etc
(Estes and Kapikian, 2007). In a microarray study following RV
infection in CaCo2 cells, induction of heat shock protein transcripts
was observed (Cuadras et al., 2002), but signiﬁcance of the Hsp
induction has not been studied. There are ample direct or indirect
evidences supporting the positive role of heat shock proteins in
modulating replication of many viruses (Connor et al., 2007; Geller et
al., 2007; Sun et al., 2008; Chase et al., 2008; Ujino et al., 2009). Thus
we hypothesized that induction of Hsp90 during rotavirus infection
Fig. 4. 17-AAG inhibits rotavirus-induced mTOR-4EBP1-p70S6K activation by Akt
regulation. Western blot showing rotavirus (SA11) induced phosphorylation of mTOR,
4EBP1 and p70S6K at 12 hpi. In the presence of 17-AAG, phosphorylation of mTOR-
4EBP1-p70S6K was inhibited 3.7, 2.0 and 2.5 fold respectively compared to only virus
treated cells. There was no change in expression of basal mTOR, 4EBP1 or p70S6K
proteins following treatment with 17-AAG. Rapamycinwas used as positive control. The
blots were reprobed with β-actin to conﬁrm equal protein loading.
Fig. 5. 17-AAG inhibits rotavirus-induced activation of Hsp90 client protein NFκB. (A)
Immunoblotting with phospho-NFκB p65 antibody revealed a signiﬁcant increase in
phosphorylation of p65 subunit (2–4 h), which was inhibited 1.75–4.5 fold (pb0.05;
n=3) in the presence of 17-AAG. There was no change in the expression of p65 in the
presence or absence of 17-AAG following 8 h of treatment. (B) NFκB promoter activity
was measured in the presence or absence of 17-AAG (4 hpi and 8 hpi) using a 2× NFκB-
luc plasmid. Signiﬁcant inhibition in activation of NFκB promoter was observed at 4 hpi
(pb0.05; n=4) and 8 hpi (⁎pb0.01) compared to only virus infected cells. Mean
relative luciferase activity of NFκB-luciferase was normalized with Renilla luciferase.
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replication. In this report, we establish that rotavirus growth is
positively dependent on Hsp90 and its downstream client proteins.
17-AAG, a cell permeable analogue of geldanamycin binds to the
ATP-binding pocket within the N-terminal domain of Hsp90 disrupt-
ing its chaperone activity (Sausville et al., 2003). Depletion of Hsp90β
and modulation of various signaling proteins following treatment
with 17-AAG in HT29 has been shown previously by gene expression
proﬁling and proteomic analysis. Downregulation of Hsp90β follow-
ing 17-AAG treatment for longer periods is probably due to
proteosomal degradation of inactive Hsp90 (Clarke et al., 2000). In
the presence of 17-AAG, reduction in viral titers was observed
irrespective of species or serotype speciﬁcity of rotaviral strains.
Similar inhibition of rotavirus growth by 17-AAG was also observed in
HT29 (24 h) and CaCo2 (40 h) cells (data not shown). At dose or time
used in the study (5 μM/24 h), 17-AAG showed minimal cytotoxicity
as determined by MTS assay or neutral red uptake, indicating that
inhibition of viral growth was not due to cytotoxicity. Moreover the
downregulation of Hsp90 expression by RNA interference also
resulted in decrease in rotavirus replication. The reduction in viral
gene transcripts or protein in the presence of 17-AAG was also not due
to global downregulation of cellular gene expression since under
similar conditions (8–12 hpi) expression of cellular genes namely β-
actin, GAPDH, Akt, mTOR, p70S6K etc was not altered. Based on the
studies where inhibitor was added at different time points after virus
infection, it can be deduced that in conditions used during the study
the anti-rotavirus effects of 17-AAG were during initial stages of
infection since the inhibitory effects of 17-AAG were signiﬁcantly
reduced when a drug was added after 4 h of adsorption compared to
0 hour post adsorption. The reduced viral growth observed during the
study is not due to inhibition in virus entry since in all experiments,
the inhibitor was added after virus adsorption (45 min). Trypsin
activated rotaviruses have been shown to internalize in MA104 cells
within 3–5 min of the adsorption (Kaljot et al., 1988).Based on our observations and lack of any previous reports, we ﬁrst
tried to elucidate the role of Hsp90 in modulating rotavirus-induced
intracellular signaling pathways. Hsp90 has been shown to interact
withmore than 100 protein kinases and associated proteins regulating
their biogenesis, stability and activity (Zhang and Burrows, 2004; Citri
et al., 2006). Hsp inhibitors have been reported to affect activities of
Akt, IkappaB kinase, receptor interacting protein (RIP), NFκB inducing
kinase (NIK), Death associated protein kinases (DAPK), cyclin
dependent kinases, p53 etc (Lewis et al., 2000; Fujita et al., 2002;
Broemer et al., 2004; Zhang and Burrows, 2004; Citri et al., 2006).
Activation of the cell survival signals like PI3K/Akt and NFκB has been
implicated in maintaining short term cell viability for facilitating
pathogen replication during infections. After the production of viral
progeny, virus particles are released by downregulation of prosurvival
pathways and induction of apoptosis (Cooray, 2004; Sun et al., 2008;
Ehrhardt and Ludwig, 2009).
PI3K/Akt activation during rotavirus infection has been shown to
modulate integrin expression and positively regulate rotavirus
replication (Halasz et al., 2008). In this study too we observed
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12 h , following rotavirus infection which was inhibited (N2.2 fold) in
the presence of 17-AAG. Unlike previous report (Halasz et al., 2008),
where Akt activation was observed from 1 h to 8 h depending on cell
type with RRV and CRW8 strains, we observed p-Akt until 12 hpi with
SA11 strain in MA104 cells, whereas following infection with KU
strain, p-Akt was observed only at 2–6 hpi (unpublished observation)
indicating strain speciﬁc differences. Importance of Akt activation
during rotavirus infection was re-conﬁrmed when triciribine, a
speciﬁc inhibitor of phospho-Akt-1 and Akt-2 (Yang et al., 2004) as
well as general PI3K inhibitor LY294002 reduced rotaviral titers in a
time dependent manner. The inhibitory effect on viral growth was not
due to non speciﬁc effects of chemical inhibitors since Akt speciﬁc
siRNAs, but not control siRNA inhibited the viral gene expression.
Based on a previous study by Halasz et al. (2008), and our
observations, it is clear that activation of PI3K/Akt positively regulates
rotavirus replication. Hsp90 chaperone cycle has been shown to
activate associated client protein Akt/PKB by phosphorylation (Citri et
al., 2006). Thus 17-AAG mediated inhibition of Hsp90 may be one of
the possible mechanisms of inhibition of Akt signaling.
Earlier in-vivo study has shown activated p70S6k in crypt cells of
rotavirus infected piglets (Rhoads et al., 2007). PI3K/Akt signaling has
also been implicated in translational control. Regulation of Tor kinase
regulates translation through two independent pathways, involving
p70S6 kinase (S6K) and the initiation factor 4E (elF-4E)-binding
protein-1 (4E-BP1). S6K phosphorylation enhances translation of 5′
TOP mRNA, containing oligopyrimidine tract which encodes for
ribosomal proteins and elongation factors (Jefferies et al., 1997).
Phosphorylation of 4E-BP1, a negative regulator of translation
initiation, inhibits its interaction with elF-4E, which binds to
m7GpppN cap of mRNA and directs its correct positioning of
ribosomal units to relieve translational block (Gingras et al., 2001).
In the presence of 17-AAG, virus induced phosphorylation of mTOR-
4EBP1-p70S6K was signiﬁcantly decreased, which could be partly
responsible for inhibition of cap-dependent translation of rotaviral
RNAs, further conﬁrming the importance of Akt signaling for virus
multiplication.
Other than Akt, Hsp90 inhibition may affect one or more other
client proteins associated with modulation of cellular homeostasis.
We looked at the effect on NFκB, since previous reports suggested
activation of NFκB by rotavirus capsid protein VP4 through interaction
with TRAF2 (La Monica et al., 2001), and induction of IL8 in rotavirus
infected intestinal epithelial cells (Casola et al., 1998; Rollo et al.,
1999). In addition Akt is also implicated in activation of NFκB via IκB
kinase pathway (Ozes et al., 1999) and disruption of Hsp90 function
has been shown to inhibit NFκB activation by modulating RIP (Lewis
et al., 2000). However recent reports have shown rotavirus mediated
inhibition of NFκB translocation to nucleus as a mechanism of
antagonizing cellular antiviral responses (Holloway et al., 2009) and
possible role of NSP1 in the process (Graff et al., 2009). In contrast
NFκB speciﬁc inhibitors have been shown to inhibit rotavirus
replication (Rossen et al., 2004). In these studies too authors have
observed activation of NFκB following RRV, Wa or NCDV infection
during initial stages but have concluded that during later stages when
rotavirus replication is established and rotavirus proteins are
expressed, nuclear translocation of p65 NFκB is inhibited to restrict
induction of NFκB driven antiviral cytokines like IFNβ or IL8 (Hollo-
way et al., 2009; Graff et al., 2009). A time course study comparing
various rotavirus strains from human and animal origin in different
cell lines may solve the ﬁne balance of both proviral and antiviral
functions of NFκB during rotavirus infection. In this study too, SA11
infection (2–8 hpi), induced both phosphorylation of p65 and NFκB
promoter activation conﬁrming previous observations. Increase in IL8
transcript (N50 fold) in MA104 cells following SA11 infection (4–
8 hpi), was also observed by real time PCR (data not shown). The
activation of virus induced NFκB was signiﬁcantly reduced in thepresence of 17-AAG indicating that NFκB inhibition also partly
contributes to antiviral effects of 17-AAG. Hsp90 may also have
additional direct effects or may modulate other unknown client
proteins during rotavirus infection which requires further studies.
Viral inhibition through regulation of cellular machinery could be
exploited further as an antiviral approach with double beneﬁts of
avoiding the development of resistant viral strains as well as having a
broad spectrum antiviral activity. In case of emergence of new variants
of virus causing outbreaks, this would prove to be useful in controlling
the infection, before viral target proteins are characterized or vaccines
are developed. This report highlights the role of chaperone protein
Hsp90 in positive regulation of rotavirus growth possibly by
modulating virus induced activation of cellular signaling pathways.
Targeting molecular chaperones like Hsp90 for developing antiviral
drugs has additional beneﬁts, i) a broad range of DNA and RNA viruses
have been reported to be inhibited by geldanamycin analogs and ii)
chaperones being evolutionarily conserved proteins, the probability of
generation of drug resistant variants is expected to be extremely low
(Geller et al., 2007). The high morbidity and mortality associated with
rotavirus-induced diarrhea, emphasize the need for evaluating low
toxicity inhibitors targeting cellular proteins as future anti-rotaviral
strategies.
Materials and methods
Chemicals
Inhibitors for Hsp90 (17-AAG), PI3Kinase (LY294002), phospho-
Akt (triciribine), mTOR (rapamycin) were purchased from Invivogen
(San Diego, CA) and Biomol (Plymouth Meeting, PA). Other ﬁne
chemicals and buffers used in the study were from Sigma-Aldrich (St.
Louis, MO).
Cell culture and virus infection
The monkey kidney cell line (MA104) was cultured in minimal
essential medium (MEM), supplemented with US certiﬁed 10% fetal
bovine serum and 1% antibiotic–antimycotic solution (Invitrogen,
Carlsbad, CA). Cells were maintained in 5% CO2 at 37 °C humidiﬁed
incubator. The simian rotavirus SA11 {H[96]} and human rotavirus Ku
strains were used in the study. For infection, viruses were activated
with acetylated trypsin (10 μg/ml) at 370 C for 30 min, diluted as per
required multiplicity of infection (moi) and added to the cells for
adsorption (45 min) at 37 °C, followed by washing 3× with media to
remove unbound virus. Infection was continued in fresh medium.
Except for viral growth assays (moi 1), moi 3 was used in the study.
The time of virus removal was taken as 0 hour post infection (hpi) for
all experiments. At different time points cells were freeze-thawed for
cell lysis. Extracted and puriﬁed viral preparations by glycerol gradient
(30–60%v/v) ultracentrifugation were titrated by plaque assay (Jolly
et al., 2000). The end point in experiments were determined based on
time required by virus to complete its replication in cells resulting in
N80% CPE as determined by neutral dye uptake assay. The end point
for SA11 and KU strain varied from 20 to 40 h depending on replication
cycle of viruses. In all experiments DMSO (≤0.25%) was added in
mock-infected controls to rule out any adverse effects of DMSO. The
different inhibitors used in the study were added after adsorption of
virus and addition of maintenance media (0 hpi).
Plaque assay
Monolayers of MA104 cells in six well plates were infected with
serial dilutions (102–108) of viral supernatants as described earlier.
After 45 min of adsorption, inoculum was removed and cells were
overlaid with 0.7% agar in 1×MEMwith 1 μg/ml trypsin. After 36–48 h
post infection second agar overlay (0.7% agar in 1×MEM with 0.1%
332 D. Dutta et al. / Virology 391 (2009) 325–333neutral red) was added and plates were incubated at 37 °C until
plaques were visualized. Viral plaque forming units were calculated as
described previously (Smith et al., 1979). N1 log inhibition in viral
titers is equivalent to N90% inhibition.Cell viability assay (MTS assay)
Cell viability in the presence or absence of different inhibitors (17-
AAG, LY294002, triciribine) was determined by Cell titer 96® Aqueous
One Solution Cell Proliferation assay kit (Promega, Medison, WI, USA)
which contains [3-(4, 5-dimethylthiazol-2-yl)-5-(3-carboxymethox-
yphenyl)-2-(4-sulphophenyl)-2H-tetrazolium, inner salt]; MTS) and
an electron coupling reagent (phenazine ethosulphate; PES). MTS gets
bioreduced to form soluble coloured formazan by NADPH or NADH
produced by dehydrogenase enzymes in metabolically active cells.
Brieﬂy, cells with ∼80% conﬂuency in 96 well plates were incubated
with different inhibitors or DMSO for indicated time periods. At the
end of each incubation period cells were treated with 20 μl of the
reagent solution in 100 μl serum free medium for 4 h at 37 °C in a
humidiﬁed 5% CO2 atmosphere. The quantity of the soluble formazan
product wasmeasured spectrophotometrically at 490 nm in Varioskan
Multimode Reader, Thermoﬁsher. The absorbance was directly
proportional to the number of living cells in culture. The percent
viability was calculated considering 100% viability for untreated
control cells at similar end points.Neutral dye uptake
Cellular activity in the presence of different inhibitors was
determined using uptake of vital stain Neutral Red (NR). The process
requires intact membranes and active metabolism in the cells. Based
on the principle that living and healthy cells take up more dye, MA104
or HT29 cells were plated on 12 well dishes to 70–80% conﬂuency.
Next day, cells were treated with different concentrations of the
inhibitors (17-AAG, triciribine or LY294002). The assay was also
utilized to determine the end point after virus infection (80% CPE).
After the requisite time intervals, plates were washedwith PBS 3× and
fresh 500 μl media containing neutral red dye (50 μg/ml) was added.
After 3 h of incubation, excess dyewaswashedwith PBS 2× and 500 μl
of desorbing solution (1% acetic acid, 50% ethanol) was added to
extract the absorbed dye. Absorbance was taken at 405 nm and
540 nm in a microplate reader. The % cell viability was calculated
considering 100% viability of untreated controls.Gel electrophoresis and immunoblot analyses
Whole cell lysateswere prepared and immunoblottingwas done as
per standard protocols (Chawla-Sarkar et al., 2002). Rabbit polyclonal
antibodies (pAb) to Akt, GSK-3 β, NFκB(P65), 4EBP1, S6K, p-Akt, p-
GSK-3 β, p-NFκB(P65), p-mTOR, p-4EBP1(Thr37/46), p-p70S6K (Cell
Signaling Inc, Devers, MA), or mouse monoclonal antibodies (mAb) to
Hsp90, Hsp70 (BD Pharmingen, San Diego, CA) were used at
concentrations recommended by the manufacturer. Rotavirus non
structural protein-1 and -4 (NSP1; NSP4) antibodies (polyclonal)
were raised in rabbit using standard protocols. Monoclonal mouse VP6
antibody (3C10) was purchased from HyTest Ltd, Turku, Finland.
Primary antibodies were detected using HRP-conjugated secondary
antibodies (Pierce, Rockford, IL) and chemiluminescent substrate
(Millipore, Billerica, MA). Blots were reprobed with anti-β-actin or
unphosphorylated proteins to conﬁrm equal protein loading. All
immunoblots in this study were repeated (n≥3) to conﬁrm results.
Blots were scanned and quantitated using GelDoc XR system and
Quantity One® software version 4.6.3 (BioRad, Hercules, CA).Dual luciferase NFκB reporter assay
The NFκB-luciferase (NFκB-luc) reporter plasmid has been
previously characterized (Elewaut et al., 1999). MA104 cells were
co-transfected with 4 μg of NFκB-luc and 0.5 μg of pRL-TK (Promega,
Madison, WI) using Lipofectamine 2000 (Invitrogen, Carlsbad, CA).
After 24 h, cells were infected with SA11 for 4 h and 12 h in the
presence or absence of 17-AAG, and luciferase activity was measured
according to the manufacturer's protocol (Promega, Madison, WI)
using a luminometer (Varioskan Multimode Reader, Thermoﬁsher).
Relative luciferase activity of NFκB-luciferase was normalized with
Renilla luciferase.
Quantitative real-time RT-PCR
Conﬂuent monolayers of MA104 cells were mock-infected or
infected with SA11 (moi 3). RNA was extracted with TRIZOL™ reagent
(Invitrogen, USA) and quantitative PCR was done in triplicates with
SYBR Green™ Mastermix using ABI7500 (Applied Biosystems Inc,
Foster city, CA). Speciﬁc primers for VP6 {VP6-F-5′GCACAGCCATTC-
GAACATCATGC-3′; VP6-R5′TGCATCGGCGAGTACAGAC TAC-3′}, Nsp4
{Nsp4-F-5′GACGGTGCAAACGAC AGGCG-3′; Nsp4-R-5′GCTGCAGT-
CACTTCTCTTGGTTC-3′}; and GAPDH {G-F-5′GAGA ACGGGAAGCTTGT-
CATC-3′; G-R-5′CATGACGAACATGGGGGCATC-3′}, were used. Relative
gene expressionwere normalized to GAPDH using the formula 2−ΔΔCT
[ΔΔCT=ΔCT (sample)−ΔCT (untreated control)].
RNA interference using siRNAs
Monolayers of MA104 cells (106 cells/ml) in 6 well plates were
transfected with either Silencer® Select Hsp90 (5nMX2;48h) cytosolic
[Ambion ID: s6995], or Silencer® Select Akt siRNA (5 nM each; 24 h)
[Ambion (ID: S659 and ID: S1216)] or 5 nM Silencer® Select Negative
Control #2 siRNA (Ambion, Foster city, CA) using siPORT™ NeoFX
transfection reagent (Ambion) according to the manufacturer's
protocol. 24 h post transfection cells were infected with SA11 (moi:
3) for 8 h or 12 h, lysed and VP6 gene expression was measured by
either quantitative PCR or immunoblotting.
Statistical analysis
Data are expressed as mean±standard deviations of at least three
independent experiments (n≥3). In all tests, pb0.05 was considered
statistically signiﬁcant. Experiments where, pb0.01 are marked (⁎).
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